180 Life Sciences Stock (NASDAQ: ATNF) stock price, news, charts, stock research, profile.
Open | $2.23 |
Close | $2.28 |
Volume / Avg. | 150.43K / 646.23K |
Day Range | 2.23 - 2.44 |
52 Wk Range | 1.31 - 21.28 |
Market Cap | $2.09M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 4.31% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of 180 Life Sciences (NASDAQ:ATNF) through any online brokerage.
Other companies in 180 Life Sciences’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG) and Entero Therapeutics (NASDAQ:ENTO).
There is no analysis for 180 Life Sciences.
180 Life Sciences has a consensus price target of $11.00.
The stock price for 180 Life Sciences (NASDAQ: ATNF) is $2.22 last updated July 23, 2024 at 6:01 PM EDT.
There are no upcoming dividends for 180 Life Sciences.
180 Life Sciences’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for 180 Life Sciences.
180 Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.